Stroke: does interrupting antiplatelet therapy raise CV risk?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Discontinuation of antiplatelet therapy is not significantly associated with increased risk for cardiovascular event in patients with acute ischemic stroke.

Why this matters

  • Antiplatelet therapy is recommended for long-term secondary stroke prevention, but discontinuation rate...